Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label, Multiple Oral-dose, 2x2 Crossover Clinical Trial to Compare the Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a AD-120 and AD-120A in Healthy Adult Volunteers
Conditions
Interventions
AD-120A
AD-120
Locations
1
South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
April 21, 2025
Primary Completion Date
September 1, 2025
Completion Date
September 1, 2025
Last Updated
April 8, 2025
NCT02616302
NCT04506593
NCT07174882
NCT07344935
NCT07179250
NCT01940185
Seung Hwan Lee, M.D., Ph.D.
CONTACT
Lead Sponsor
Addpharma Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions